[ Price : $8.95]
FDA warns Chinas Hong Qiangxing Shenzhen Electronics about Quality System violations in its production of several medical devices....[ Price : $8.95]
FDA warns Baton Rouge, LA-based Owen Biosciences about CGMP violations in its production of finished drugs as a contract manufactu...[ Price : $8.95]
FDA approves Novartis Itvisma (onasemnogene abeparvovec-brve), a new formulation of a gene therapy for a broader age of spinal mus...[ Price : $8.95]
FDA issues a draft guidance with recommendations to help master file holders determine to which Center to submit cross-Center mast...[ Price : $8.95]
National Center for Health Research president Diana Zuckerman defends FDA advisory committees, saying they do a more thorough job ...[ Price : $8.95]
Novo Nordisk reports favorable Phase 2 data for its investigational dual-action obesity and diabetes drug amycretin, showing signi...[ Price : $8.95]
A new study of FDA advisory committee meetings reveals that a substantial portion of public speakers support drug approval, and ma...[ Price : $8.95]
FDA releases the form FDA-483 with six observations from an inspection at the Catalent Indiana sterile drug manufacturing facility...